APOCEPT Trademark

Trademark Overview


On Friday, December 8, 2006, a trademark application was filed for APOCEPT with the United States Patent and Trademark Office. The USPTO has given the APOCEPT trademark a serial number of 77060169. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 22, 2017. This trademark is owned by Apogenix GmbH. The APOCEPT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for the treatment of pneumonitis; pharmaceutical products and preparations for the treatment of graft-versus-host disease (GVHD); pharmaceutical products and preparations for the treatment of acute cardiovascular diseases; pharmaceutical products and preparations for the treatment of cancer diseases; pharmaceutical products and preparations for the treatment of skin disorders; pharmaceutical products and preparations for the treatment of wound healing; pharmaceutical products and preparations for the treatment of transplant rejection/graft rejection; pharmaceutical products and preparations for use in the treatment of diseases by modulating effects such as cell proliferation, cell differentiation, cell migration, and cell death; all of the foregoing goods excluding pharmaceutical products and preparations for the treatment of cerebral and neurological disorders, diseases and conditions
apocept

General Information


Serial Number77060169
Word MarkAPOCEPT
Filing DateFriday, December 8, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 22, 2017
Registration Number3918394
Registration DateTuesday, February 15, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2007

Trademark Statements


Goods and ServicesPharmaceutical products and preparations for the treatment of pneumonitis; pharmaceutical products and preparations for the treatment of graft-versus-host disease (GVHD); pharmaceutical products and preparations for the treatment of acute cardiovascular diseases; pharmaceutical products and preparations for the treatment of cancer diseases; pharmaceutical products and preparations for the treatment of skin disorders; pharmaceutical products and preparations for the treatment of wound healing; pharmaceutical products and preparations for the treatment of transplant rejection/graft rejection; pharmaceutical products and preparations for use in the treatment of diseases by modulating effects such as cell proliferation, cell differentiation, cell migration, and cell death; all of the foregoing goods excluding pharmaceutical products and preparations for the treatment of cerebral and neurological disorders, diseases and conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameApogenix GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address69120 Heidelberg
DE

Party NameApogenix GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address69120 Heidelberg
DE

Party NameApogenix GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address69120 Heidelberg
DE

Trademark Events


Event DateEvent Description
Friday, September 22, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, February 15, 2011REGISTERED-PRINCIPAL REGISTER
Friday, January 7, 2011TTAB RELEASE CASE TO TRADEMARKS
Friday, January 7, 2011OPPOSITION TERMINATED NO. 999999
Friday, January 7, 2011OPPOSITION DISMISSED NO. 999999
Monday, December 6, 2010PAPER RECEIVED
Friday, November 27, 2009ASSIGNED TO EXAMINER
Tuesday, November 20, 2007OPPOSITION INSTITUTED NO. 999999
Tuesday, August 14, 2007EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 24, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2007NOTICE OF PUBLICATION
Friday, June 15, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 15, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 14, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, June 14, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 14, 2007EXAMINERS AMENDMENT E-MAILED
Thursday, June 14, 2007EXAMINERS AMENDMENT -WRITTEN
Monday, June 11, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 11, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 11, 2007ASSIGNED TO LIE
Thursday, May 24, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 3, 2007PRIORITY ACTION E-MAILED
Tuesday, April 3, 2007PRIORITY ACTION WRITTEN
Monday, April 2, 2007ASSIGNED TO EXAMINER
Wednesday, December 13, 2006NEW APPLICATION ENTERED IN TRAM